VAXIMM is a privately held, Swiss/German biotech company that is developing oral T-cell immunotherapies for patients suffering from cancer. VAXIMM’s product platform is based on a live attenuated, safe, orally available bacterial vaccine strain, which is modified to stimulate patients’ cytotoxic T-cells to target specific structures of the tumor. The Company has a pipeline of complementary development candidates targeting different tumor structures. Lead product candidate, oral VXM01, activates killer cells targeting tumor-specific vasculature and certain immune-suppressive cells, thereby increasing immune cell infiltration in solid tumors. VXM01 is currently in clinical development for several tumor types, including brain cancer. VAXIMM has completed a clinical trial evaluating VXM01 in combination with the human anti-PD-L1 antibody, avelumab, as part of a scientific collaboration with Merck KGaA, Darmstadt, Germany. VAXIMM also has a collaboration agreement with China Medical System Holdings (CMS), granting CMS full rights in China and other Asian countries (excluding Japan) to VAXIMM’s existing programs. VAXIMM AG is headquartered in Basel, Switzerland. Its wholly owned subsidiary, VAXIMM GmbH, located in Mannheim, Germany, is responsible for the Company’s development activities.
View Top Employees from VAXIMM AGWebsite | http://www.vaximm.com |
Revenue | $405000 |
Funding | $8 million |
Employees | 3 (3 on RocketReach) |
Founded | 2008 |
Address | 60c Hochbergerstrasse, Basel, Basel-City 4057, CH |
Phone | +41 61 316 91 11 |
Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Developer Platform, Software, Therapeutics, Health Care |
Web Rank | 14 Million |
Competitors | Gilead Sciences, Juno Therapeutics, Inc., Takeda China, bluebird bio, 华润生物医药(深圳)有限公司 |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular VAXIMM AG employee's phone or email?
The VAXIMM AG annual revenue was $405000 in 2024.
3 people are employed at VAXIMM AG.
VAXIMM AG is based in Basel, Basel-City.
The NAICS codes for VAXIMM AG are [54171, 54, 541, 5417, 541713].
The SIC codes for VAXIMM AG are [873, 87].